Staphylococcus Aureus Infections Disease – Global Clinical Trials Review, H1 2020

Pages: 345 Published: May 30, 2020 Report Code: GDHC6246CTIDB

GlobalData's clinical trial report, “Staphylococcus aureus Infections Global Clinical Trials Review, H1, 2020" provides an overview of Staphylococcus aureus Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Staphylococcus aureus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

  • Merck & Co Inc

    Pfizer Inc

    AstraZeneca Plc

    GlaxoSmithKline Plc

    AbbVie Inc

    KYORIN Holdings Inc

    LegoChem Biosciences Inc

    TaiGen Biopharmaceuticals Holdings Ltd

    Wockhardt Ltd

    AmpliPhi Biosciences Corp (Inactive)

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Staphylococcus aureus Infections to Infectious Disease Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Staphylococcus aureus Infections to Infectious Disease Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 29

Clinical Trials by End Point Status 31

Subjects Recruited Over a Period of Time 32

Clinical Trials by Sponsor Type 33

Prominent Sponsors 34

Top Companies Participating in Staphylococcus aureus Infections Therapeutics Clinical Trials 36

Prominent Drugs 38

Latest Clinical Trials News on Staphylococcus aureus Infections 39

Mar 03, 2020: Destiny Pharma provides update on clinical and business update 39

Feb 21, 2020: Arch scientist publishes data on the pre-clinical efficacy of AB569 in killing of drug resistant bacteria 39

Clinical Trial Profile Snapshots 40

Appendix 343

Abbreviations 343

Definitions 343

Research Methodology 344

Secondary Research 344

About GlobalData 345

Contact Us 345

Source 346

List of Tables

List of Tables

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials by Region, 2020* 8

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Staphylococcus aureus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

Staphylococcus aureus Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

Staphylococcus aureus Infections Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

Staphylococcus aureus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

Staphylococcus aureus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of Staphylococcus aureus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2020* 18

Staphylococcus aureus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 19

Staphylococcus aureus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 21

Proportion of Staphylococcus aureus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2020* 23

Staphylococcus aureus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 24

Staphylococcus aureus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 26

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials by Phase, 2020* 27

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 28

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2020* 30

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2020* 31

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 32

Staphylococcus aureus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 33

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 35

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 37

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 38

List of Figures

List of Figures

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Staphylococcus aureus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

Staphylococcus aureus Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

Staphylococcus aureus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

Staphylococcus aureus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

Staphylococcus aureus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of Staphylococcus aureus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2020* 17

Staphylococcus aureus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 19

Staphylococcus aureus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 20

Proportion of Staphylococcus aureus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2020* 22

Staphylococcus aureus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 24

Staphylococcus aureus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 25

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2020* 27

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 28

Staphylococcus aureus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2020* 29

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2020* 31

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 32

Staphylococcus aureus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 33

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 34

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 36

Staphylococcus aureus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 38

GlobalData Methodology 344

Frequently Asked Questions

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.